0000899243-22-011327.txt : 20220316 0000899243-22-011327.hdr.sgml : 20220316 20220316205600 ACCESSION NUMBER: 0000899243-22-011327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220312 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: George Sean E CENTRAL INDEX KEY: 0001627766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 22746470 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-12 0 0001501134 Invitae Corp NVTA 0001627766 George Sean E C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 1 1 0 0 President & CEO Common Stock 2022-03-12 4 A 0 44117 0.00 A 844376 D Common Stock 2022-03-14 4 S 0 31389 6.6866 D 812987 D Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2023, subject to continued service with the issuer through such vesting date. Includes an aggregate of 240,625 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. Represents a weighted average sale price. Actual sale prices ranged from $6.6866 to $6.6867 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. /s/ Thomas R. Brida, Attorney-in-Fact 2022-03-16